Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9504 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9504 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9143 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9143 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9078 |
High Similarity |
NPD1549 |
Phase 2 |
0.906 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.9048 |
High Similarity |
NPD4380 |
Phase 2 |
0.9 |
High Similarity |
NPD1510 |
Phase 2 |
0.8993 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8986 |
High Similarity |
NPD7411 |
Suspended |
0.8936 |
High Similarity |
NPD2796 |
Approved |
0.8849 |
High Similarity |
NPD1240 |
Approved |
0.8816 |
High Similarity |
NPD7075 |
Discontinued |
0.8767 |
High Similarity |
NPD1511 |
Approved |
0.8742 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8742 |
High Similarity |
NPD7819 |
Suspended |
0.8723 |
High Similarity |
NPD1607 |
Approved |
0.8693 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.869 |
High Similarity |
NPD3750 |
Approved |
0.8675 |
High Similarity |
NPD1934 |
Approved |
0.8649 |
High Similarity |
NPD1512 |
Approved |
0.8618 |
High Similarity |
NPD2801 |
Approved |
0.8599 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD3749 |
Approved |
0.8553 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD6801 |
Discontinued |
0.8526 |
High Similarity |
NPD6959 |
Discontinued |
0.8506 |
High Similarity |
NPD7768 |
Phase 2 |
0.8493 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8389 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8367 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8367 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8365 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8365 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8365 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8345 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8299 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8269 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8228 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8219 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.821 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8207 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8205 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8163 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8163 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8163 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8163 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.816 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.816 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8121 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.811 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8108 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8105 |
Intermediate Similarity |
NPD920 |
Approved |
0.8105 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8079 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8061 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8042 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8038 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8012 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7974 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7974 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7974 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7974 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7973 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7958 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7952 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7947 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7947 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7908 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7904 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7902 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7895 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7891 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7891 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7879 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7879 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7867 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7862 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7861 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7861 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7852 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7852 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7832 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7823 |
Intermediate Similarity |
NPD943 |
Approved |
0.7801 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7801 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7801 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.777 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7762 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7746 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7716 |
Intermediate Similarity |
NPD919 |
Approved |
0.7712 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7688 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7671 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7622 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7614 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7614 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7586 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7586 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7584 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7574 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7562 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD2654 |
Approved |
0.753 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7529 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7516 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7486 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD5710 |
Approved |
0.747 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7453 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7453 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7451 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7451 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7451 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7451 |
Intermediate Similarity |
NPD5405 |
Approved |
0.745 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.745 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7443 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7431 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7421 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7412 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7372 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7348 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7347 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD411 |
Approved |
0.7317 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7303 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7303 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7294 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD17 |
Approved |
0.729 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7262 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7262 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7254 |
Intermediate Similarity |
NPD9493 |
Approved |
0.725 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7244 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7241 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7233 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7233 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7225 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7195 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7179 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7163 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7158 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7158 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7158 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7158 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7158 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7158 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7152 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7115 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7107 |
Intermediate Similarity |
NPD3295 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7093 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7089
|
Intermediate Similarity |
NPD1652 |
Phase 2 |